The 5-methylcytosine reader Y-box binding protein 1 promotes the growth of colorectal cancer by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15
Precision medicine in cancer and translational studies|更新时间:2025-11-20
|
The 5-methylcytosine reader Y-box binding protein 1 promotes the growth of colorectal cancer by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15
Journal of Chongqing Medical UniversityVol. 50, Issue 11, Pages: 1506-1514(2025)
Xia Shusen,Zhu Yanbin,Liu Lixin,et al.The 5-methylcytosine reader Y-box binding protein 1 promotes the growth of colorectal cancer by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15[J].Journal of Chongqing Medical University,2025,50(11):1506-1514.
Xia Shusen,Zhu Yanbin,Liu Lixin,et al.The 5-methylcytosine reader Y-box binding protein 1 promotes the growth of colorectal cancer by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15[J].Journal of Chongqing Medical University,2025,50(11):1506-1514. DOI: 10.13406/j.cnki.cyxb.003738.
The 5-methylcytosine reader Y-box binding protein 1 promotes the growth of colorectal cancer by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15
To investigate the molecular mechanism of the 5-methylcytosine(m5C) reader Y-box binding protein 1(YBX1) in participating in the development and progression of colorectal cancer(CRC) by regulating the stability of the ferroptosis inhibitor membrane-spanning 4-domains subfamily A 15(MS4A15).
Methods
2
Bioinformatics databases were used to investigate the mRNA and protein expression levels of YBX1 i
n CRC. RT-qPCR was used to measure the expression level of YBX1 in CRC cells. LC-MS was used to measure the level of m5C modification in CRC cells and normal colorectal mucosal cells. CCK-8 assay was used to observe the effect of YBX1 on the proliferation of CRC cells,Transwell assay was used to observe its effect on the migration ability of CRC cells,and flow cytometry was sued to observe its effect on the apoptosis of CRC cells. Bioinformatics methods were used to identify the ferroptosis inhibitors that can interact with YBX1 and potential m5C modification sites. GEPIA2 was used to analyze the association between the expression of YBX1 and MS4A15. The expression of YBX1 was inhibited,and then the mRNA expression level and m5C modification level of MS4A15 were analyzed. The catRAPID database was used to find the binding sites between YBX1 protein and MS4A15 mRNA. CRC cells were treated with actinomycin D after inhibition of YBX1 expression,and RT-qPCR was used to measure the stability of MS4A15 mRNA. The expression of MS4A15 was inhibited,and then the proliferative activity,migration ability,and apoptosis rate of cells were measured,as well as the expression levels of the key indicators for ferroptosis,including MDA,ROS,and Fe
2+
.
Results
2
High mRNA and protein expression levels of YBX1 were observed in CRC,and YBX1 was highly expressed in CRC cells. The m5C modification level of CRC cells was significantly higher than that of normal colorectal mucosal cells. YBX1 could promote the proliferation and migration of CRC cells and inhibit the apoptosis of CRC cells. The bioinformatics analysis showed that YBX1 was positively correlated with the expression level of the ferroptosis inhibitor MS4A15,and there were multiple m5C modification sites on MS4A15. Inhibition of YBX1 expression could reduce the mRNA expression level and m5C modification level of MS4A15 and the stability of MS4A15 mRNA. There were significant reductions in the proliferative activity and migration ability o
f CRC cells and a significant increase in the apoptosis rate of CRC cells after inhibition of MS4A15 expression,with significant increases in the content of MDA,ROS,and Fe
2+
.
Conclusion
2
These results show that YBX1 promotes the development and progression of CRC by stabilizing MS4A15 via m5C modification,which provides a promising targeted therapeutic strategy for CRC patients.
关键词
Keywords
references
Kanth P , Inadomi JM . Screening and prevention of colorectal cancer [J ] . BMJ , 2021 , 374 : n1855 .
Biller LH , Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review [J ] . JAMA , 2021 , 325 ( 7 ): 669 - 685 .
Zhang YX , Zhang LS , Dai Q , et al . 5-methylcytosine(m5C) RNA modification controls the innate immune response to virus infection by regulating type I interferons [J ] . Proc Natl Acad Sci USA , 2022 , 119 ( 42 ): e2123338119 .
Guo GQ , Pan K , Fang S , et al . Advances in mRNA 5-methylcytosine modifications: Detection,effectors,biological functions,and clinical relevance [J ] . Mol Ther Nucleic Acids , 2021 , 26 : 575 - 593 .
Chen X , Li A , Sun BF , et al . 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs [J ] . Nat Cell Biol , 2019 , 21 ( 8 ): 978 - 990 .
Kim A , Shim S , Kim YH , et al . Inhibition of Y Box Binding Protein 1 Suppresses Cell Growth and Motility in Colorectal Cancer [J ] . Mol Cancer Ther , 2020 , 19 ( 2 ): 479 - 489 .
Liang DG , Minikes AM , Jiang XJ . Ferroptosis at the intersection of lipid metabolism and cellular signaling [J ] . Mol Cell , 2022 , 82 ( 12 ): 2215 - 2227 .
Guo JP , Xu BF , Han Q , et al . Ferroptosis: A Novel Anti-tumor Action for Cisplatin [J ] . Cancer Res Treat , 2018 , 50 ( 2 ): 445 - 460 .
Lu QR , Guo P , Wang XH , et al . MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia [J ] . Cell Biol Toxicol . 2023 , 39 ( 1 ): 201 - 216 .
Sung H , Ferlay J , Siegel RL , et al . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
Poturnajova M , Furielova T , Balintova S , et al . Molecular features and gene expression signature of metastatic colorectal cancer(Review) [J ] . Oncol Rep , 2021 , 45 ( 4 ): 10 .
Hu YB , Chen CB , Tong XY , et al . NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation [J ] . Cell Death Dis , 2021 , 12 ( 9 ): 842 .
Chen YS , Yang WL , Zhao YL , et al . Dynamic transcriptomic m5C and its regulatory role in RNA processing [J ] . Wiley Interdiscip Rev RNA , 2021 , 12 ( 4 ): e1639 .
Yin HF , Huang ZJ , Niu SQ , et al . 5-Methylcytosine(m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis [J ] . Front Immunol , 2022 , 13 : 967921 .
Yang L , Zhang YW , Zhang YY , et al . Mechanism and application of ferroptosis in colorectal cancer [J ] . Biomed Pharmacother , 2023 , 158 : 114102 .
Liang YG , Su Q , Wu X . Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer [J ] . Front Oncol , 2021 , 10 : 571655 .
Lee S , Hwang N , Seok BG , et al . Autophagy mediates an amplification loop during ferroptosis [J ] . Cell Death Dis , 2023 , 14 ( 7 ): 464 .
Lou JS , Zhao LP , Huang ZH , et al . Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer [J ] . Phytomedicine , 2021 , 80 : 153370 .